As weight loss jabs like Ozempic and Wegovy become ever more popular, doctors are growing increasingly concerned about their gnarly side effects. As Germany's Deutsche Welle notes, people who take glucagon-like peptide-1 (GLP-1) agonist/receptors, the class of drugs that the popular jabs fall under that mimic the stomach's feeling of fullness, have reported everything from stomach issues and vision changes to erectile dysfunction and even suicide. Troubling as those side effects can be, doctors are more concerned about the more serious adverse effects that can occur with injectable diabetes and weight loss like Novo Nordisk's Ozempic or Eli Lilly's Mounjaro. […]